Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

15 Dec 2022 07:00

RNS Number : 7596J
Zotefoams PLC
15 December 2022
 

Zotefoams plc

("Zotefoams" or "Group" or "Company")

 

Trading Update

Continued positive momentum through Q4 and full year profit ahead of market expectations

 

15 December 2022 - Zotefoams, a world leader in cellular materials technology, today provides an update in respect of its financial year ending 31 December 2022.

As communicated in the Group's trading update of 13 October, performance over the nine months to 30 September 2022 had been strong, with revenues approximately 24% ahead of the comparable prior year period. 

Encouragingly, trading during October and November has remained strong, with both the Polyolefin Foams and High-Performance Products businesses continuing to deliver year-on-year growth as well as a continued focus on cost and efficiency. As a result, based on current FX rates, the Board now expects Group FY22 adjusted profit before income tax to be ahead of current market expectations*, with the extent of the outperformance primarily dependent on the timing of customer shipments in the final weeks of the year.

Cash generation also continues to be positive. The better than anticipated earnings performance should contribute to an appreciable reduction in leverage compared with that reported in the interims at 30 June 2022. 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"I am pleased that Zotefoams continues to perform well and deliver excellent growth in both revenue and profitability. Whilst this year has seen considerable challenges in the form of both cost and demand volatility, we have continued to demonstrate resilience in mitigating these, which is testament to Zotefoams' well-established products and experienced team.

"Whilst we expect a number of the challenges experienced this year to continue into 2023, we are confident in our ability to respond and we continue to see significant opportunity for the Group."

 

* Current Company-compiled consensus expectations for adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2022, is £10.7m.

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZMMZRDKGZZM
Date   Source Headline
15th Apr 20257:00 amRNSIssue of Equity
11th Apr 20254:14 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Apr 20253:25 pmRNSHolding(s) in Company
2nd Apr 20254:37 pmRNSDirector Declaration
20th Mar 20253:16 pmRNSHolding(s) in Company
19th Mar 20251:52 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSPreliminary Results
17th Mar 20251:00 pmRNSResults Presentation on Investor Meet Company
12th Mar 20252:50 pmRNSNotification Of Transactions Of Directors/PDMRs
10th Mar 20257:00 amRNSStrategic Investment in Asia
4th Mar 20254:41 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSCFO Retirement
27th Feb 20253:58 pmRNSHolding(s) in Company
12th Feb 20251:35 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 202511:34 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSTrading Update & Notice of Capital Markets Day
15th Jan 202511:04 amRNSNotification Of Transactions Of Directors/PDMRs
24th Dec 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Dec 20247:00 amRNSUpdate on ReZorce
13th Dec 20243:41 pmRNSHolding(s) in Company
12th Dec 20249:47 amRNSNotification Of Transactions Of Directors/PDMRs
26th Nov 20244:21 pmRNSHolding(s) in Company
25th Nov 20245:51 pmRNSHolding(s) in Company
12th Nov 20242:27 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20247:00 amRNSTrading Update
14th Oct 202410:02 amRNSNotification Of Transactions Of Directors/PDMRs
8th Oct 20242:17 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Sep 20241:20 pmRNSNotification Of Transactions Of Directors/PDMRs
23rd Aug 202411:42 amRNSHolding(s) in Company
14th Aug 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
6th Aug 20247:00 amRNSInterim Results
12th Jul 20244:14 pmRNSNotification Of Transactions Of Directors/PDMRs
8th Jul 20247:00 amRNSNotice of Results and Investor Presentation
5th Jul 20241:14 pmRNSHolding(s) in Company
13th Jun 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
5th Jun 20243:08 pmRNSNotification Of Transactions Of Directors/PDMRs
31st May 20244:45 pmRNSHolding(s) in Company
30th May 20243:07 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd May 20242:01 pmRNSResult of the 2024 Annual General Meeting
22nd May 20247:00 amRNSTrading Update and Group CEO Succession
15th May 202410:07 amRNSNotification Of Transactions Of Directors/PDMRs
15th May 20247:00 amRNSUpdate on ReZorce® & beverage carton Media Launch
10th May 20247:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
7th May 20247:00 amRNSZotefoams and Shincell Global Alliance
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.